Novozymes A/S

Copenhagen Stock Exchange NSIS-B.CO

Novozymes A/S Operating Income Margin for the year ending December 31, 2023: 22.21%

Novozymes A/S Operating Income Margin is 22.21% for the year ending December 31, 2023, a -15.77% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Novozymes A/S Operating Income Margin for the year ending December 31, 2022 was 26.37%, a -1.60% change year over year.
  • Novozymes A/S Operating Income Margin for the year ending December 31, 2021 was 26.80%, a 2.83% change year over year.
  • Novozymes A/S Operating Income Margin for the year ending December 31, 2020 was 26.06%, a 4.41% change year over year.
  • Novozymes A/S Operating Income Margin for the year ending December 31, 2019 was 24.96%, a -13.61% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
Copenhagen Stock Exchange: NSIS-B.CO

Novozymes A/S

CEO Ms. Ester Baiget
IPO Date Nov. 20, 2000
Location Denmark
Headquarters Krogshoejvej 36
Employees 10,452
Sector Health Care
Industries
Description

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

StockViz Staff

January 15, 2025

Any question? Send us an email